Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation

Updated:Feb 20,2013
AHA_MPT_CVDaily Banner PON_ScienceNews_DiscussThis



Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

Circ Journal Cover for Science News

  • Cardiovascular disease is a major cause of morbidity and mortality for those with end-stage non-cardiac organ failure both before and after transplantation.
  • The unique characteristics of end-organ failure transplant candidates require careful consideration during cardiac evaluation.
  • This paper addresses gaps in existing guidelines for consideration during cardiac disease evaluation in kidney and liver transplant candidates.
 
Read the full article in Circulation
Circulation. 2012: published online before print July 2, 2012, 10.1161/CIR.0b013e31823eb07a.

Supporting Materials
  • Commentary:  Bringing Harmony to the Cacophony of Cardiovascular Disease Assessment for Potential Kidney Liver Transplant Candidates. A Case for Assimilating the New AHA/ACCF Guidelines by Christopher deFilippi, MD
  • Top 10 Things To Know
Other Resources
Related Statements and Guidelines

Did you see these recent Commentaries?

Commentaries View All


Connect with AHA Science News

twitter_FollowAHAScience
fb_LikeAHAScienceNews

Network with over 31,000 Heart and Stroke Professionals

DS-5610 PON Banner 280X137
  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org

Science News View All